The Florey Institute of Neuroscience and Mental Health

Patent Applications and Registrations

Patent applications and USPTO patent grants for The Florey Institute of Neuroscience and Mental Health.The latest application filed is for "prophylaxis and treatment of cognitive dysfunction and decline".

Company Profile

9.11.15

The Florey Institute of Neuroscience and Mental Health - Melbourne AU
The Florey Institute of Neuroscience and Mental Health - Parkville, Victoria AU
The Florey Institute of Neuroscience and Mental Health - Victoria N/A AU
The Florey Institute of Neuroscience and Mental Health - Melbourne, Victoria AU
THE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH - Parkville Victoria AU
The Florey Institute of Neuroscience and Mental Health - Malbourne, Victoria AU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
4H-pyran compounds as insulin-regulated aminopeptidase (IRAP) inhibitors Grant 11306066 -	2022-04-19
Prophylaxis And Treatment Of Cognitive Dysfunction And Decline App 20210121489 - Adlard; Paul ; et al.	2021-04-29
Methods of treating neurodevelopmental diseases and disorders Grant 10,933,043 - Cheung , et al. March 2, 2	2021-03-02
Encapsulation Of Eukaryotic Cells For Cellular Screening Of Expressed Sequences App 20210054530 - Scott; Daniel James ; et al.	2021-02-25
Methods For Evaluating And Improving Cognitive Function App 20200348318 - BOON; Wah Chin ; et al.	2020-11-05
Proteinaceous Molecules And Methods Of Use App 20200299339 - PETROU; Steven ; et al.	2020-09-24
Compositions And Methods For Treating Conditions Associated With Gain-of-function Mutations In Kcnt1 App 20200129538 - PETROU; Steven	2020-04-30
Sodium channel modulators Grant 10,577,308 - Williams , et al.	2020-03-03
Methods of Treating Neurodevelopmental Diseases and Disorders App 20190314315 - CHEUNG; Steve ; et al.	2019-10-17
Methods of treating neurodevelopmental diseases and disorders Grant 10,251,856 - Cheung , et al.	2019-04-09
Methods of Treating or Alleviating Mental Disorders and Associated Symtoms App 20180353452 - BOON; Wah Chin ; et al.	2018-12-13
Modified relaxin B chain peptides Grant 10,081,662 - Bathgate , et al. September 25, 2	2018-09-25
Methods of Treating Neurodevelopmental Diseases and Disorders App 20180214405 - CHEUNG; Steve ; et al.	2018-08-02
Modulation of Physiological Processes and Agents Useful for Same App 20180177839 - Bush; Ashley I. ; et al.	2018-06-28
4H-Pyran Compounds as Insulin-Regulated Aminopeptidase (IRAP) Inhibitors App 20180170891 - CHAI; Siew Yeen ; et al.	2018-06-21
Methods of treating neurodevelopmental diseases and disorders Grant 9,925,163 - Cheung , et al. March 27, 2	2018-03-27
Sodium Channel Modulators App 20180072656 - Williams; Spencer John ; et al.	2018-03-15
Methods for determining binding capability of target ligands with G protein-coupled receptors using translocation through nanochannels Grant 9,791,453 - Downton , et al. October 17, 2	2017-10-17
Methods of Treating Neurodevelopmental Diseases and Disorders App 20170087110 - CHEUNG; Steve ; et al.	2017-03-30
Modified Relaxin B Chain Peptides App 20170037106 - BATHGATE; Ross Alexander David ; et al.	2017-02-09
Modifying single proteins (GPCR), ligands, and nanopore surfaces to create binding-induced molecular changes of protein-ligand complexes detected in nanochannel translocation Grant 8,835,362 - Downtown , et al. September 16, 2	2014-09-16
Modifying Single Proteins (gpcr), Ligands, And Nanopore Surfaces To Create Binding-induced Molecular Changes Of Protein-ligand Complexes Detected In Nanochannel Translocation App 20140179541 - Downtown; Matthew ; et al.	2014-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.